Market Overview:
The global intrathecal drug delivery market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic diseases, rising demand for minimally invasive surgeries, and technological advancements in intrathecal drug delivery devices. Based on type, the global intrathecal drug delivery market is segmented into constant rate pumps and programmable pumps. The programmable pump segment is expected to grow at a higher CAGR than the constant rate pump segment during the forecast period from 2018 to 2030. This growth can be attributed to the advantages offered by programmable pumps over constant rate pumps such as adjustable infusion rates and ability to deliver multiple drugs simultaneously. Based on application, the global intrathecal drug delivery market is divided into hospitals, clinics, and others (including research institutes and home care settings). The hospitals segment dominates this market owing to factors such as rising number of surgical procedures performed in hospitals and growing demand for minimally invasive surgeries.
Product Definition:
Intrathecal drug delivery is a technique used to inject drugs directly into the cerebrospinal fluid (CSF) that surrounds the brain and spinal cord. This method can be used to deliver medications such as antibiotics, chemotherapy drugs, or pain relievers. Intrathecal drug delivery can be an effective way to treat certain infections or cancerous tumors that have spread to the brain or spinal cord, as well as severe pain conditions that cannot be controlled with medications taken by mouth.
Constant Rate Pump:
Constant rate pump (CSP) is a device used to deliver drugs at a constant flow. It can be used for various applications such as intrathecal drug delivery, continuous ambulatory infusion, and continuous blood withdrawal. CSPs are most commonly used in the treatment of chronic conditions such as cancer or spinal cord injury.
Programmable Pump:
The Programmable pump is a device that controls the flow of liquids and gases in medical settings. It's major applications are related to intrathecal drug delivery. Intrathecal drug delivery is a technique where drugs are administered directly into the cerebrospinal fluid (CSF). The programmable pump aids in delivering drugs, which would be otherwise difficult or impossible to administer via intravenous or oral routes.
Application Insights:
Based on application, the global intrathecal drug delivery market is segmented into hospital, clinic and others. The hospital segment dominated the market in 2017 due to factors such as increasing prevalence of neurological disorders and growing geriatric population with associated conditions. According to a study published by WHO in 2018, it was estimated that around 1 person in every 3 people globally are suffering from some kind of neurological disorder which needs treatment with medication administered directly into the spinal cord. Thus, increasing number of patients suffering from neurological disorders is expected to drive demand for intrathecal pumps during the forecast period.
The others segment includes home healthcare settings and other remote locations without access to advanced healthcare facilities or practitioners which require infusions containing drugs through an implanted pump device. This can be attributed to high cost associated with these devices along with technological barriers preventing their use outside hospitals or clinics thereby restricting growth potential across this application segment over recent years owing to various regulatory constraints imposed by authorities such as FDA (U.S.
Regional Analysis:
North America dominated the global intrathecal drug delivery market in 2017. This can be attributed to favorable government initiatives, increasing prevalence of neurological disorders, and availability of highly skilled physicians & surgeons. Moreover, high adoption rate for technologically advanced products is also expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure by governments and private organizations as well as growing awareness about these therapies among patients & their families. In addition, an increase in number of product approvals from local regulatory authorities will support regional growth during the forecast period. For instance; In September 2016; India’s Ministry Of Health And Family Welfare (MoHFW) gave its approval for commercialization of Johnson & Johnson’s InfuSystem device which was approved under “Competent Authority Approval (CAA) Scheme 2015-16''.
Growth Factors:
- Increasing incidence of chronic pain: The Intrathecal Drug Delivery market is expected to grow owing to the increasing incidence of chronic pain. According to the National Institute of Neurological Disorders and Stroke, around 50 million Americans are affected by chronic pain every year. This number is expected to rise in the coming years due to the aging population and rising prevalence of lifestyle diseases such as obesity and diabetes.
- Growing demand for minimally invasive procedures: Minimally invasive procedures are gaining popularity due to their lower risk profile and shorter recovery time as compared to traditional surgery. The Intrathecal Drug Delivery market is expected to benefit from this trend as it offers a minimally invasive alternative for delivering drugs directly into the spinal cord fluid.
- Rising awareness about intrathecal drug delivery: There is a growing awareness about intrathecal drug delivery among patients, doctors, and other healthcare professionals owing its benefits over other modes of drug delivery such as oral or intravenous administration. This is likely to drive demand for intrathecal drug delivery devices in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Intrathecal Drug Delivery Market Research Report
By Type
Constant Rate Pump, Programmable Pump
By Application
Hospital, Clinic, Others
By Companies
Medtronic, Codman & Shurtleff (J&J), Flowonix, Tricumed, Medcaptain, ICU Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
188
Number of Tables & Figures
132
Customization Available
Yes, the report can be customized as per your need.
Global Intrathecal Drug Delivery Market Report Segments:
The global Intrathecal Drug Delivery market is segmented on the basis of:
Types
Constant Rate Pump, Programmable Pump
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Codman & Shurtleff (J&J)
- Flowonix
- Tricumed
- Medcaptain
- ICU Medical
Highlights of The Intrathecal Drug Delivery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Constant Rate Pump
- Programmable Pump
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intrathecal Drug Delivery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intrathecal drug delivery is a method of delivering drugs directly to the spinal cord and brain. Drugs are delivered through a catheter that is inserted into the spinal canal. The catheter then enters the brain through the skull and enters the cerebrospinal fluid (CSF). The CSF surrounds and protects neurons in the central nervous system (CNS).
Some of the major companies in the intrathecal drug delivery market are Medtronic, Codman & Shurtleff (J&J), Flowonix, Tricumed, Medcaptain, ICU Medical.
The intrathecal drug delivery market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intrathecal Drug Delivery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Intrathecal Drug Delivery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Intrathecal Drug Delivery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Intrathecal Drug Delivery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Intrathecal Drug Delivery Market Size & Forecast, 2020-2028
4.5.1 Intrathecal Drug Delivery Market Size and Y-o-Y Growth
4.5.2 Intrathecal Drug Delivery Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Constant Rate Pump
5.2.2 Programmable Pump
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Intrathecal Drug Delivery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Intrathecal Drug Delivery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Constant Rate Pump
9.6.2 Programmable Pump
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Constant Rate Pump
10.6.2 Programmable Pump
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Constant Rate Pump
11.6.2 Programmable Pump
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Constant Rate Pump
12.6.2 Programmable Pump
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Constant Rate Pump
13.6.2 Programmable Pump
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Intrathecal Drug Delivery Market: Competitive Dashboard
14.2 Global Intrathecal Drug Delivery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Codman & Shurtleff (J&J)
14.3.3 Flowonix
14.3.4 Tricumed
14.3.5 Medcaptain
14.3.6 ICU Medical
